Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07843420 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus

Name: Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus — clinical trial record (NCT07843420)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 2

SponsorMayo Clinic

Started2026-11

View on ClinicalTrials.gov ↗

Mayo Clinic

1,015 trials monitored

See 115 trials at risk

The purpose of this research is to investigate the efficacy of nemolizumab in the treatment of adults with moderate to severe chronic hepatic pruritus.

Trial Details

NCT Number	NCT07843420
Lead Sponsor	Mayo Clinic
Conditions	Chronic Hepatic Pruritus, Cholestatic Liver Disease, Primary Biliary Cholangitis, Cholestasis, Primary Sclerosing Cholangitis
Enrollment	15 participants
Start Date	2026-11
Primary Completion	2028-11 (estimated)
Study Completion	2028-11 (estimated)
Updated on ClinicalTrials.gov	2026-09-28